Breaking News Instant updates and real-time market news.

MDXG

MiMedx

$8.87

0.1 (1.14%)

08:40
10/06/16
10/06
08:40
10/06/16
08:40

MiMedx to present seven abstracts on EpiFix and AmnioFix at SAWC meeting

MiMedx announced that seven poster abstracts showing the clinical and cost effective healing results of the company's EpiFix and AmnioFix dehydrated Human Amnion/Chorion Membrane allografts will be presented at the 2016 Symposium on Advanced Wound Care Fall between October 7 and October 9. The seven poster abstracts will report on the clinical and cost effectiveness of EpiFix and AmnioFix dHACM allografts in the healing of diabetic foot ulcers, chronic diabetic lower extremity ulcerated wounds, venous leg ulcers, complex wounds, and hard-to-treat wounds.

  • 09

    Nov

  • 10

    Nov

MDXG MiMedx
$8.87

0.1 (1.14%)

05/17/16
PIPR
05/17/16
NO CHANGE
Target $12
PIPR
Overweight
Osiris false claims lawsuit another overhang, says Piper Jaffray
After MiMedx (MDXG) announced that it has filed suit against Osiris (OSIR), asserting that Osiris "knowingly and willfully made false and misleading representations," Piper Jaffray analyst Edward Tenthoff said it is unclear at this time what merit the claims have, but added that the lawsuit represents "yet another" overhang for Osiris shares. Noting that he expects BioSurgery sales to return Osiris to profitability, Tenthoff maintains an Overweight rating and $12 price target on the stock.
06/29/16
BMUR
06/29/16
NO CHANGE
Target $12
BMUR
Buy
MiMedx expects second half acceleration, says Brean Capital
Brean Capital said MiMedx continues to be confident in Q2 but expects a second half acceleration with surgical uptake the key opportunity. The firm's doctor checks suggest growing interest in using amniotic tissue for tendon repair procedures along with GI surgeons showing interest as well. Brean Capital reiterated its Buy rating and $12 price target on MiMedx shares.
07/27/16
BMUR
07/27/16
NO CHANGE
Target $12
BMUR
Buy
MiMedx shares remain undervalued, says Brean Capital
Brean Capital believes Mimedx shares remain undervalued following Q2 earnings. The firm said higher spending cutting into its earnings was a disappointment but at this stage in the company's development they noted the focus is on top-line growth, which remains healthy. Brean Capital reiterated its Buy rating and $12 price target on MiMedx shares.
08/31/16
BMUR
08/31/16
NO CHANGE
Target $12
BMUR
Buy
MiMedx Epifix trial news removes major overhang, says Brean Capital
Brean Capital analyst Jason Wittes said the surprise announcement that MiMedx is close to completing DFU and VLU trials for Epifix ahead of the September FDA hearing to discuss the regulator's guidance on human cells, tissues, and cellular and tissue based products removes a major overhang for the stock. The analyst felt most investors assumed the company was not positioned to immediately address the potential for increased regulatory requirements given their strong stance against up-regulation. Wittes reiterated his Buy rating and $12 price target on MiMedx shares.

TODAY'S FREE FLY STORIES

06:50
04/27/17
04/27
06:50
04/27/17
06:50
General news
Front-month WTI crude prices are down 1% »

Front-month WTI crude…

EXAS

Exact Sciences

$23.80

-1.09 (-4.38%)

06:50
04/27/17
04/27
06:50
04/27/17
06:50
Technical Analysis
Exact Sciences hits new 52-week high after results »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 30

    May

  • 06

    Jun

BWA

BorgWarner

$41.06

0.22 (0.54%)

06:49
04/27/17
04/27
06:49
04/27/17
06:49
Earnings
BorgWarner now sees FY17 EPS $3.50-$3.60, consensus $3.41 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

SDPI

Superior Drilling

$0.79

-0.0099 (-1.24%)

06:49
04/27/17
04/27
06:49
04/27/17
06:49
Earnings
Breaking Earnings news story on Superior Drilling »

Superior Drilling sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOW

Dow Chemical

$64.33

-0.48 (-0.74%)

06:48
04/27/17
04/27
06:48
04/27/17
06:48
Hot Stocks
Breaking Hot Stocks news story on Dow Chemical »

Dow Chemical reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

  • 11

    May

DOW

Dow Chemical

$64.33

-0.48 (-0.74%)

06:48
04/27/17
04/27
06:48
04/27/17
06:48
Hot Stocks
Dow Chemical reports Q1 EBITDA $2.1B »

Q1 operating EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

  • 11

    May

BWA

BorgWarner

$41.06

0.22 (0.54%)

06:47
04/27/17
04/27
06:47
04/27/17
06:47
Earnings
BorgWarner sees Q2 EPS 87c-91c, consensus 87c »

Sees Q2 organic net sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

RHHBY

Roche

$32.20

-0.207 (-0.64%)

06:47
04/27/17
04/27
06:47
04/27/17
06:47
Hot Stocks
Roche CEO Severin Schwan says 'well on track' to meet full-year targets »

Commenting on the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 06

    Jun

  • 26

    Jun

RHHBY

Roche

$32.20

-0.207 (-0.64%)

06:46
04/27/17
04/27
06:46
04/27/17
06:46
Earnings
Roche reports Q1 group sales CHF12.94B vs. CHF12.41B last year »

Group sales increased 4%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 06

    Jun

  • 26

    Jun

BWA

BorgWarner

$41.06

0.22 (0.54%)

06:46
04/27/17
04/27
06:46
04/27/17
06:46
Earnings
BorgWarner reports Q1 EPS 89c, consensus 84c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

XRF

China Rapid Finance

06:45
04/27/17
04/27
06:45
04/27/17
06:45
Syndicate
China Rapid Finance 10M share IPO price range lowered to $6.00-$7.00 »

China Rapid Finance 10M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

DOW

Dow Chemical

$64.33

-0.48 (-0.74%)

06:45
04/27/17
04/27
06:45
04/27/17
06:45
Earnings
Dow Chemical reports Q1 operating EPS $1.04, consensus 98c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

  • 11

    May

HP

Helmerich & Payne

$65.21

-0.18 (-0.28%)

06:45
04/27/17
04/27
06:45
04/27/17
06:45
Earnings
Helmerich & Payne reports Q2 EPS (45c) with items, consensus (40c) »

Reports Q2 revenue $405M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

RHHBY

Roche

$32.20

-0.207 (-0.64%)

06:44
04/27/17
04/27
06:44
04/27/17
06:44
Hot Stocks
Roche confirms FY17 outlook, sees sales up low to mid single digits »

In 2017, Roche expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 06

    Jun

  • 26

    Jun

BSX

Boston Scientific

$25.97

0.23 (0.89%)

06:44
04/27/17
04/27
06:44
04/27/17
06:44
Earnings
Boston Scientific baks FY17 adj. EPS view of $1.22-$1.26, consensus $1.25 »

Raises FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 07

    Jun

  • 27

    Jun

AKAM

Akamai

$62.24

0.44 (0.71%)

06:43
04/27/17
04/27
06:43
04/27/17
06:43
Downgrade
Akamai rating change  »

Akamai downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 08

    Jun

  • 15

    Jun

CSCO

Cisco

$33.40

-0.02 (-0.06%)

, SPLK

Splunk

$63.72

-0.13 (-0.20%)

06:43
04/27/17
04/27
06:43
04/27/17
06:43
Upgrade
Credit Suisse double upgrades Cisco on possible M&A transformation »

Cisco Systems'…

CSCO

Cisco

$33.40

-0.02 (-0.06%)

SPLK

Splunk

$63.72

-0.13 (-0.20%)

NOW

ServiceNow

$90.92

0.68 (0.75%)

PANW

Palo Alto Networks

$109.27

-1.13 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 12

    Jun

WCC

WESCO

$68.00

0.6 (0.89%)

06:42
04/27/17
04/27
06:42
04/27/17
06:42
Earnings
WESCO sees Q2 sales down 2% to up 1%, consensus $1.92B »

Sees Q2 operating margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

  • 07

    Jun

WCC

WESCO

$68.00

0.6 (0.89%)

06:42
04/27/17
04/27
06:42
04/27/17
06:42
Earnings
WESCO backs FY17 EPS $3.60-$4.00, consensus $3.87 »

Backs FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 31

    May

  • 07

    Jun

BSX

Boston Scientific

$25.97

0.23 (0.89%)

06:42
04/27/17
04/27
06:42
04/27/17
06:42
Earnings
Boston Scientific reports Q1 adj. EPS 29c, consensus 30c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 07

    Jun

  • 27

    Jun

ICLR

ICON plc

$76.83

-0.54 (-0.70%)

06:42
04/27/17
04/27
06:42
04/27/17
06:42
Earnings
ICON plc raises FY17 EPS view to $5.06-$5.26 from $5.00-$5.20, consensus $5.10 »

Backs FY17 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

EXAS

Exact Sciences

$23.80

-1.09 (-4.38%)

06:41
04/27/17
04/27
06:41
04/27/17
06:41
Hot Stocks
Exact Sciences sign collaboration agreement with MDxHealth »

MDxHealth announced that …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 30

    May

  • 06

    Jun

STAY

Extended Stay America

$17.45

0.26 (1.51%)

06:41
04/27/17
04/27
06:41
04/27/17
06:41
Hot Stocks
Extended Stay America declares Q1 distribution of 21c per share »

Extended Stay America and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

BSX

Boston Scientific

$25.97

0.23 (0.89%)

06:41
04/27/17
04/27
06:41
04/27/17
06:41
Earnings
Boston Scientific sees Q2 adj. EPS 30c-32c, consensus $31c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

  • 07

    Jun

  • 27

    Jun

ICLR

ICON plc

$76.83

-0.54 (-0.70%)

06:40
04/27/17
04/27
06:40
04/27/17
06:40
Earnings
ICON plc reports Q1 EPS $1.29, consensus $1.27 »

Reports Q1 revenue $432M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.